Navigation Links
Stemedica International Announces Joint Venture with AnC Bio Group
Date:10/5/2010

SAN DIEGO, Oct. 5 /PRNewswire/ -- Stemedica International, S.A., ("Stemedica"), a wholly owned subsidiary of Stemedica Cell Technologies, Inc., announced the signing of an agreement to form a joint venture with AnC Bio, a global manufacturer of stem cell-based products.  The new venture, StemedicaAnC, will manufacture stem cells developed by Stemedica for the treatment of ischemic stroke and other degenerative disorders.  The initial manufacturing capacity of this alliance will produce enough products to meet the Company's five-year revenue projections, with an expansion capacity to manufacture multiple stem cell products to meet the anticipated long-term growth of the international market for stem cells.  

AnC's biomanufacturing facility was built at an estimated cost of 120 million dollars over a five year period.  "The synergy between Stemedica's technology and AnC's technically advanced manufacturing facility positions StemedicaAnC as the global leader in stem cell production," said Nikolai Tankovich, MD, PhD, Stemedica's President and Chief Medical Officer.  "The facility will provide StemedicaAnC with the capacity to manufacture its multiple allogeneic stem cell products to meet international safety and quality standards established by the United States FDA, Swissmedic, the European regulatory agency and Korea's FDA."

"We are pleased to be working with Stemedica to accelerate the advancement of stem cell therapy," said Alex Choi, Chairman and Chief Executive Officer of the AnC Bio Group.  "This joint venture will provide stem cell products to institutions around the world that are conducting clinical trials and stem cell research."

"We have invested significant time and effort in our search for a best-in-class stem cell manufacturing facility to accommodate our technology," said Roger J. Howe, PhD, Executive Chairman of Stemedica.  "AnC Bio provides an excellent fit for our international business development strategy."

"This is an exciting time for both companies," said Ike W. Lee, PhD, President and Chief Technology Officer of AnC Bio.  "Stemedica's advanced technology and operating systems will be a significant addition to AnC Bio's manufacturing facility.  I am looking forward to working with their team of scientists and engineers."

The joint venture will be overseen by a Board of Directors representing both Stemedica and AnC Bio.  Planning for operations is expected to begin by year end.

About Stemedica Cell Technologies, Inc.Stemedica Cell Technologies, Inc. (www.stemedica.com) is a specialty biopharmaceutical company that develops and manufactures best-in-class adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and human clinical trials.  The company is currently developing regulatory pathways for neurology, cardiology, ophthalmology, wound care and dermatology. Stemedica is headquartered in San Diego, California.  For more information regarding Stemedica Cell Technologies, Inc. contact Dave McGuigan at dmcguigan@stemedica.com

About AnC Bio GroupAnC Bio Group is a Korean Corporation with three operating divisions: the cell therapy division which includes a state-of-the-art cell culture cGMP facility; the artificial organs division that designs, manufactures and distributes artificial human organs such as kidney dialysis and artificial combined heart and lung machines; and the vaccine division that develops, manufactures and distributes various kinds of cell culture-based vaccines including influenza, avian, Alzheimer's and anthrax. For more information regarding AnC Bio, please visit www.ancbio.com. Media contact:Dave McGuiganStemedica Cell Technologies Inc.+18586580910dmcguigan@stemedica.comhttp://www.stemedica.com
'/>"/>

SOURCE Stemedica International, S.A.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. United States Patent and Trademark Office Publishes Stemedicas Patent Application for the Treatment of Diabetic Retinopathy
2. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
3. Stemedica Requests Pre-IND Meeting With FDA
4. Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain
5. Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting
6. Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites
7. International Robotic Urology Symposium 2011
8. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
9. Mindray Medical to Exhibit New Products at 64th China International Medical Equipment Fair
10. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
11. Webmedx and NLP International Team to Bring Natural Language Processing Software to Medical Transcription
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
Breaking Medicine News(10 mins):